MedTrace Logo

Direct Mechanical Thrombectomy Versus Bridging Therapy

NCT05155540 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2022-01-03

No results posted yet for this study

Summary

This study compares the efficacy and safety of direct mechanical thrombectomy versus bridging therapy in patients with anterior circulation large vessel occlusion in a cohort of patients treated at the stroke unit of a single centre at Alexandria University in Egypt.

Conditions

  • Thrombectomy
  • Ischemic Stroke
  • Large-Artery Atherosclerosis (Embolus/Thrombosis)

Interventions

DEVICE

Trevo and or Merci devices for stent retreival

FDA approved devices for stent retrieval during mechanical thrombectomy

DEVICE

Penumbra system for stent aspiration

FDA approved devices for stent aspiration during mechanical thrombectomy

DRUG

recombinant tissue plasminogen activator

FDA approved drug for treatment of acute ischemic stroke within 4.5 hours of strokeonset

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Mohamed A Abdel Ghani, Master's · Alexandria University Faculty of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2020-07-01
Completion
2020-09-01
FDA Drug
Yes
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05155540 on ClinicalTrials.gov